Cargando…

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)

PURPOSE: To systematically review the literature describing the efficacy, effectiveness, and safety of raloxifene for postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia). MATERIALS AND METHODS: Medline via PubMed and Embase was systematically searched using prespecified ter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujiwara, Saeko, Hamaya, Etsuro, Sato, Masayo, Graham-Clarke, Peita, Flynn, Jennifer A, Burge, Russel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226459/ https://www.ncbi.nlm.nih.gov/pubmed/25395843 http://dx.doi.org/10.2147/CIA.S70307

Ejemplares similares

Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial
por: Lee, You-Bin, et al.
Publicado: (2022)

Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study
por: Tanaka, Ikuko, et al.
Publicado: (2013)

The Gut Microbiome Is Altered in Postmenopausal Women With Osteoporosis and Osteopenia
por: Rettedal, Elizabeth A, et al.
Publicado: (2021)

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia
por: Graham-Clarke, Peita L, et al.
Publicado: (2020)

Bone fractures and feeling at risk for osteoporosis among women in Japan: patient characteristics and outcomes in the National Health and Wellness Survey
por: Sato, Masayo, et al.
Publicado: (2014)

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2009)

Prevalence and Predictors of Osteoporosis and Osteopenia in Postmenopausal Women of Punjab, India
por: Khinda, Rubanpal, et al.
Publicado: (2022)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
por: Messalli, Enrico M, et al.
Publicado: (2010)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Discovery and Identification of Serum Succinyl‐Proteome for Postmenopausal Women with Osteoporosis and Osteopenia
por: Zhang, Li‐li, et al.
Publicado: (2019)

Treatment for Osteoporosis among Women in Japan: Associations with Patient Characteristics and Patient-Reported Outcomes in the 2008–2011 Japan National Health and Wellness Surveys
por: Sato, Masayo, et al.
Publicado: (2014)

Psychometric properties of the osteoporosis assessment questionnaire (OPAQ) 2.0: results from the multiple outcomes of raloxifene evaluation (MORE) study
por: Shen, Wei, et al.
Publicado: (2014)

Osteopenia-osteoporosis discrimination in postmenopausal women by (1)H NMR-based metabonomics
por: Pontes, T. A., et al.
Publicado: (2019)

10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea
por: Baek, Yeon-Hee, et al.
Publicado: (2021)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
por: Gazoni, Fernanda Martins, et al.
Publicado: (2023)

Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis
por: Islander, Ulrika, et al.
Publicado: (2011)

Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
por: Chen, Mingsheng, et al.
Publicado: (2016)

Use of health-related quality of life measures to predict health utility in postmenopausal osteoporotic women: results from the Multiple Outcomes of Raloxifene Evaluation study
por: Burge, Russel, et al.
Publicado: (2013)

Relationship between Two Panoramic Radiography Indices and Bone Mineral Density of Postmenopausal Women with Osteopenia and Osteoporosis
por: Navabi, Nader, et al.
Publicado: (2018)

Specific Bioactive Collagen Peptides in Osteopenia and Osteoporosis: Long-Term Observation in Postmenopausal Women
por: Zdzieblik, Denise, et al.
Publicado: (2021)

The importance of the UGT1A1 variants in the development of osteopenia and osteoporosis in postmenopausal women
por: Bogacz, Anna, et al.
Publicado: (2021)

Inferring Bacterial Community Interactions and Functionalities Associated with Osteopenia and Osteoporosis in Taiwanese Postmenopausal Women
por: Kuo, Yi-Jie, et al.
Publicado: (2023)

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022)

Proteomic profiling analysis of postmenopausal osteoporosis and osteopenia identifies potential proteins associated with low bone mineral density
por: Huang, Dageng, et al.
Publicado: (2020)

Burden of Osteopenia and Osteoporosis Among Postmenopausal Women in India: A Systematic Review and Meta-Analysis
por: Anupama, D. S., et al.
Publicado: (2022)

Association of inflammatory markers with all-cause mortality and cardiovascular mortality in postmenopausal women with osteoporosis or osteopenia
por: Qu, Li, et al.
Publicado: (2023)

Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women
por: van Essen, Huib W., et al.
Publicado: (2007)

Osteoporosis, osteopenia, and atherosclerotic vascular disease
por: Aronow, Wilbert S.
Publicado: (2011)

Osteopenia and osteoporosis associated with hyperprolactinemic antipsychotics
por: Montejo, A. L., et al.
Publicado: (2023)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2010)

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis
por: Foster, Shonda A, et al.
Publicado: (2013)

Nutrient Patterns and Risk of Osteopenia in Postmenopausal Women
por: Grili, Patricia Paula da Fonseca, et al.
Publicado: (2023)

Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2010)

The Impact of Rheumatoid Arthritis on Bone Loss: Links to Osteoporosis and Osteopenia
por: Kareem, Roaa, et al.
Publicado: (2021)

Change in Bone Mineral Density in Stroke Patients with Osteoporosis or Osteopenia
por: Lee, Do-Hee, et al.
Publicado: (2022)

Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
por: Shin, Chang Jin, et al.
Publicado: (2016)

Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures
por: Iwamoto, Jun, et al.
Publicado: (2009)

Effects of Vitamin K(2) on the Development of Osteopenia in Rats as the Models of Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_o5r0teuf35f1h766vk0q4q3t9q